Search

everythinglearnresearchcommunity

for

Search:↓

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Treating cystoid macular oedema in uveitis is difficult and risky.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Medical terms make new health issues seem more serious but don't affect views on well-known conditions.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

P-cadherin is important for hair growth and health, and its problems can cause hair and skin disorders.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

AGA affects many, progresses differently, and early treatment is crucial.

Androgens can cause hair growth in some areas but hair loss on the scalp.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Androgens can both increase body hair and cause scalp hair loss.